Intellia Therapeutics Inc buy Wells Fargo & Company
Start price
08.08.25
/
50%
€9.49
Target price
08.08.26
-
Performance (%)
3.31%
Price
20:17
€9.80
Summary
This prediction is currently active. With a performance of 3.31%, the BUY prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc is trending in the right direction. This prediction currently runs until 08.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intellia Therapeutics Inc | 6.570% |
| iShares Core DAX® | -0.347% |
| iShares Nasdaq 100 | -0.687% |
| iShares Nikkei 225® | -2.075% |
| iShares S&P 500 | 0.351% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.50
28.02.25
28.02.25
€48.09
28.02.26
28.02.26
2.57%
20:17
20:17
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.22
10.01.25
10.01.25
€58.40
10.01.26
10.01.26
-4.66%
20:17
20:17
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.35
18.11.24
18.11.24
€66.07
18.11.25
18.11.25
-26.98%
20:17
20:17